BIOMAT Database Logo BIOMAT Database Logo

Neuroleptic malignant syndrome induced by metoclopramide. 1991

A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Clinique de Neurologie, CHU Timone, Marseille, France.

Neuroleptic malignant syndrome (NMS) associated with metoclopramide is rare. NMS probably results from neuroleptic-induced dopamine receptor blockade. We describe a case and have found only seven reports of metoclopramide-induced NMS in the literature.

UI MeSH Term Description Entries
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D009459 Neuroleptic Malignant Syndrome A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72) Neuroleptic-Induced Neuroleptic Malignant Syndrome,Neuroleptic-Malignant Syndrome, Neuroleptic Induced,NMS (Neuroleptic Malignant Syndrome),NMSs (Neuroleptic Malignant Syndrome),Neuroleptic Induced Neuroleptic Malignant Syndrome,Neuroleptic Malignant Syndrome, Neuroleptic Induced,Neuroleptic Malignant Syndromes,Syndrome, Neuroleptic Malignant,Syndromes, Neuroleptic Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Metoclopramide induced neuroleptic malignant syndrome.
January 1993, Neurology India,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Metoclopramide-induced neuroleptic malignant syndrome.
August 1987, Archives of internal medicine,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Neuroleptic malignant-like syndrome induced by metoclopramide.
January 1987, Movement disorders : official journal of the Movement Disorder Society,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Neuroleptic malignant syndrome induced by metoclopramide in an infant with Freeman-Sheldon syndrome.
September 2006, Anesthesia and analgesia,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Neuroleptic malignant syndrome associated with metoclopramide.
December 1985, Journal of neurology, neurosurgery, and psychiatry,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Neuroleptic malignant syndrome associated with metoclopramide.
January 1988, British medical journal (Clinical research ed.),
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Neuroleptic malignant syndrome associated with metoclopramide.
May 1988, Southern medical journal,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Neuroleptic malignant syndrome associated with metoclopramide.
May 1999, The Annals of pharmacotherapy,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene.
October 1991, Australian and New Zealand journal of medicine,
A Donnet, and J R Harle, and J C Dumont, and A Alif Cherif
Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy.
February 1992, Gynecologic oncology,
Copied contents to your clipboard!